Latest interview of Mr. Khoraiwala to NDTV.
-
Nothing much new, he could not quantify the market size of Nafithromycin. This drug will most likely be launched in FY25. WCK 5222 will mostly like be launched in FY26.
-
Wockhardt has two patents for Nafithromycin. One will expire in 2031 and second will expire in 2037.
-
Also for WCK 5222 they have two patents. India patent will expire in 2031/32 and I am assuming for other countries, it will expire in 2037.
India Market Open | Wockhardt And Shyam Metalics In Focus | NDTV Profit
Disclosure – Invested.
| Subscribe To Our Free Newsletter |
